Literature DB >> 1678767

Stable expression of transfected human involucrin gene in various cell types: evidence for in situ cross-linking by type I and type II transglutaminase.

E A Rorke1, R L Eckert.   

Abstract

Involucrin is a 68-kd precursor of the cornified envelope in keratinocytes. During terminal differentiation, involucrin becomes covalently cross-linked to other proteins by a membrane-anchored calcium-activated transglutaminase (TG) to form part of the cornified envelope. To better understand this process, we have used vector-mediated gene transfer to express human involucrin in a variety of cell types. Authentic involucrin protein was expressed in Chinese hamster ovarian (CHO) cells (fibroblasts), PtK2 rat kangaroo kidney cells (simple epithelial), and rat epidermal keratinocytes (stratifying squamous epithelial). The expression vector included an independent transcription unit encoding the aminoglycoside phosphotransferase gene (neo-r) allowing selection of stable involucrin-positive, G418-resistant clonal cell lines. In each cell type, involucrin levels were comparable to the endogenous expression observed in SCC-13 cells. Immunofluorescence localization studies revealed a uniform involucrin distribution throughout the cytoplasm in each cell type. Elevation of intracellular calcium resulted in cross-linking of involucrin in both CHO cells and rat keratinocytes, a process that was inhibited by EDTA and cystamine. In contrast, no cross-linking was observed in PtK2 cells or long-term passaged rat keratinocytes. Transglutaminase assays showed that rat keratinocytes contain predominantly a particulate (type I) form, whereas CHO cells contain only soluble TG (type II). PtK2 cells and long-term passaged keratinocytes, which were unable to cross-link involucrin, contained barely detectable TG activity. These results indicate 1) that involucrin is an efficient in situ substrate for both type I and type II transglutaminase and 2) that involucrin cross-linking is strictly TG dependent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678767     DOI: 10.1111/1523-1747.ep12481579

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  2 in total

Review 1.  Transglutaminase induction by various cell death and apoptosis pathways.

Authors:  L Fesus; A Madi; Z Balajthy; Z Nemes; Z Szondy
Journal:  Experientia       Date:  1996-10-31

2.  Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma.

Authors:  Yanjie Han; Xinxin Li; Jiliang Yan; Chunyan Ma; Xin Wang; Hong Pan; Xiaoli Zheng; Zhen Zhang; Biao Gao; Xin-Ying Ji
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.